Gibco™ CTS™ RevitaCell™ Supplement (100X)

CTS RevitaCell Supplement (100X) is a cGMP-manufactured, animal origin-free, chemically defined supplement that is used with pluripotent stem cells (PSCs)

• cGMP-manufactured, animal origin-free, chemically defined supplement that is used with pluripotent stem cells (PSCs), either as a post-thaw recovery solution to improve cell viability or in combination with CTS™ Essential 8 Medium to enhance single cell passaging applications
• Reduces the burden in qualifying reagents when transitioning from the research bench to the clinic
• Facilitates regulatory filings through cGMP manufacturing and the availability of documentation
• Simplifies the transition from bench to clinic through the direct replacement of RUO RevitaCell Supplement

Facilitates regulatory filings
CTS™ RevitaCell Supplement is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS™ RevitaCell Supplement.

Simplifies transition from bench to clinic
Like the RUO RevitaCell Supplement, the CTS™ RevitaCell Supplement maximizes cell viability post-single cell passaging and yields high post-thaw cell viability and growth of pluripotent stem cells.  Both the RUO and CTS™ RevitaCell supplements include a ROCK inhibitor that has higher specificity than the traditional inhibitors, coupled with molecules containing antioxidant and free radical scavenger properties that minimize the impact of stress on the cells.  With its additional safety testing, including adventitious agents, CTS™ RevitaCell Supplement enables a smooth transition from RUO RevitaCell Supplement.

Content And Storage

Store at -5 to -20°C and protect from light.

Cell Type

Pluripotent Stem Cells (PSCs)

Classification

Animal Origin-free, Chemically-defined

Concentration

100X

Form

Liquid

Product Type

Supplement

Sterility

Sterile-filtered

For Use With (Application)

Cell and Gene Therapy Research, Development and Manufacturing

Manufacturing Quality

ISO 13485, MDSAP, FDA-registered, 21 CFR 820

Quantity

5 mL

Remarks

Supplied at a concentration of 0.9 mg/mL

Shipping Condition

Dry Ice

For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.